TrademarkDir
ELOHIMED
LIVE

Serial Number

79255291

Owner

M. Guy Faustin MONKAM NITCHEU

Attorney

Susan J. Brushaber

Filing Date

Oct 30, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ELOHIMED Trademark

Serial Number: 79255291 • Registration: 6010165

ELOHIMED is a trademark filed by M. Guy Faustin MONKAM NITCHEU on October 30, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

M. Guy Faustin MONKAM NITCHEU

47 rue de Béthune

Entity Type: 01

Trademark Details

Filing Date

October 30, 2018

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

Pharmaceutical products for the treatment of metabolic syndrome disorders, infectious diseases, and complications associated therewith; pharmaceutical products for the prevention and/or treatment of cancer and metastases; pharmaceutical products for use in the prevention and/or treatment of infection, especially HIV; pharmaceutical products for the treatment of bacterial, fungal or viral diseases; pharmaceutical products for the treatment of liver diseases; pharmaceutical products for the treatment and/or prevention of inflammatory, cardiovascular and neurodegenerative diseases; dietetic substances adapted for medical use, namely, capsules, pills, infusions, and tinctures for metabolic syndrome diseases, cancer, bacterial, fungal or viral diseases, particularly HIV; Herbal teas for medicinal purposes

Retail store services and wholesale store services for pharmaceutical products; business advice services, namely, commercial information for consumers; distribution of goods, namely, distribution of pharmaceutical products for advertising purposes; all the aforesaid services relating to pharmaceutical products and medicines

Research and development in the scientific, medical and industrial fields, namely, pharmaceutical industrial fields; research and development of new pharmaceutical products; laboratory research relating to pharmaceuticals; laboratory research services in the field of gene expression, namely, in the field of cancer; laboratory research in the field of bacteriology, fungal or viral disease; clinical research, namely, conducting clinical trials for others; clinical research in the field of oncology; research and development of new products for others in the pharmaceutical and medical field; scientific research for medical purposes; research and development in the field of vaccines; providing scientific research information in the field of pharmaceutical, medical, health and well-being products through on-line computer networks, for customers

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 30, 2020 FICS
FINAL DISPOSITION PROCESSED
Jun 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2020 REAP
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2019 CNEA
EXAMINER'S AMENDMENT ENTERED
Nov 20, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 20, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 20, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 20, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2019 TROA
REFUSAL PROCESSED BY IB
May 18, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 1, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 5, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Apr 5, 2019 MAFR
NON-FINAL ACTION WRITTEN
Apr 4, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2019 REPR

Related Trademarks